KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.265 $5.95 Friday, 26th Apr 2024 WINT stock ended at $5.23. This is 3.15% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.89% from a day low at $5.06 to a day high of $5.51.
90 days $0.265 $5.95
52 weeks $0.265 $5.95

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
Mar 04, 2016 $2.05 $2.14 $2.02 $2.02 24 700
Mar 03, 2016 $2.02 $2.17 $2.01 $2.04 20 200
Mar 02, 2016 $2.17 $2.20 $1.92 $2.02 139 800
Mar 01, 2016 $2.03 $2.03 $1.96 $1.99 22 300
Feb 29, 2016 $2.02 $2.06 $1.90 $2.00 18 700
Feb 26, 2016 $2.13 $2.16 $2.00 $2.01 23 200
Feb 25, 2016 $2.19 $2.34 $2.01 $2.10 171 200
Feb 24, 2016 $2.20 $2.23 $2.13 $2.20 2 700
Feb 23, 2016 $2.21 $2.27 $2.20 $2.20 6 200
Feb 22, 2016 $2.28 $2.29 $2.10 $2.26 28 200
Feb 19, 2016 $2.28 $2.44 $2.26 $2.27 18 300
Feb 18, 2016 $2.36 $2.44 $2.25 $2.32 17 300
Feb 17, 2016 $2.28 $2.53 $2.28 $2.43 40 200
Feb 16, 2016 $2.30 $2.38 $2.24 $2.32 31 100
Feb 12, 2016 $2.24 $2.30 $2.24 $2.29 36 100
Feb 11, 2016 $2.27 $2.46 $2.20 $2.25 13 100
Feb 10, 2016 $2.44 $2.49 $2.30 $2.30 12 900
Feb 09, 2016 $2.36 $2.50 $2.29 $2.43 47 400
Feb 08, 2016 $2.42 $2.55 $2.42 $2.49 25 000
Feb 05, 2016 $2.50 $2.53 $2.27 $2.47 38 700
Feb 04, 2016 $2.23 $2.58 $2.12 $2.51 44 400
Feb 03, 2016 $2.33 $2.42 $2.07 $2.30 116 500
Feb 02, 2016 $2.17 $2.17 $2.17 $2.17 0
Feb 01, 2016 $2.17 $2.17 $2.17 $2.17 0
Jan 29, 2016 $2.17 $2.17 $2.17 $2.17 0
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT